|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR RENAL TOXICITY, BRONCHOSPASM, AND HYPOTENSION
|
POTENTIAL FOR RARE LIFE-THERATENING HEPATIC VENO-OCCLUSIVE DISEASE
|
|
|
|
|
ZIDOVUDINE HEMATOLOGIC TOXICITY IS INCREASED BY THE CYTOTOXIC DRUGS
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
ANTICOAGULANT EFFECT IS REDUCED
|
CO-ADMINISTRATION WITH HMG-COA REDUCTASE INHIBITORS THAT ARE METABOLIZED BY CYP3A PATHWAY, SUCH AS ATORVASTATIN, INCREASE THE RISK OF MYOPATHY & RHABDOMYOLYSIS
|
IMMUNOSUPPRESSANT DRUGS CONCOMITANT USE MAY INCREASE CHANCES OF DEVELOPING MYOPATHY
|
IMMUNOSUPPRESSANT DRUGS CONCOMITANT USE MAY INCREASE CHANCES OF DEVELOPING MYOPATHY
|
IMMUNOSUPPRESSANT DRUGS CONCOMITANT USE MAY INCREASE CHANCES OF DEVELOPING MYOPATHY
|
IMMUNOSUPPRESSANT DRUGS CONCOMITANT USE MAY INCREASE CHANCES OF DEVELOPING MYOPATHY
|
ALLOPURINOL REDUCES RENAL CLEARANCE OF THE DRUG SO THE DRUG DOSE SHOULD BE REDUCED TO 1/3 OR 1/4
|
5-AMINO SALICYLIC ACID INHIBITS THE METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
LOPINAVIR INCREASES ITS PLASMA LEVELS
|